Overview
Share price change
24h
Current
Min
21.13
Max
21.55
Income | -22M -127M |
|---|---|
Sales | 143K 284K |
EPS | -1.05 |
Profit margin | -44,760.211 |
Employees | 252 |
EBITDA | -17M -119M |
Next Earnings | 4 lis 2026 |
|---|
Market Cap | 464M 2.6B |
|---|---|
Previous open | 26.23 |
Previous close | 21.16 |
News Sentiment
By Acuity
50%
50%
126 / 339 Ranking in Healthcare
VIRIDIAN THERAPEUTICS INC Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
11 wrz 2026, 23:26 UTC
Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Recent U.S. inflation data adds broader context.
Read
10 wrz 2026, 20:13 UTC
Viridian Therapeutics Inc. shares are higher in after-market trading, though they remain below the 20-day moving average and near the lower end of their one-month range.
Read
9 wrz 2026, 21:02 UTC
Viridian Therapeutics Inc shares are lower in after-market hours, declining from an initial drop to a more pronounced decrease amid weak trading.
Read
8 wrz 2026, 20:13 UTC
Viridian Therapeutics Inc shares are higher in after-market trading. No specific news was identified to explain the price movement.
Read
3 wrz 2026, 19:16 UTC
Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026. Shares are slightly higher during Thursday's session.
Read
2 wrz 2026, 22:06 UTC
Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026, with a fireside chat accessible via a live webcast. Shares are little changed.
Read
28 sie 2026, 20:02 UTC
Viridian Therapeutics Inc shares are lower today, breaking a trend of higher closes. Broader market pressures from rising U.S. Treasury yields may be influencing this decline.
Read
27 sie 2026, 22:01 UTC
Viridian Therapeutics Inc shares are lower in after-market hours, reflecting notable weakness following a flat start to the session. No specific news was identified.
Read
25 sie 2026, 20:07 UTC
Viridian Therapeutics is gaining amid a broader positive market trend, despite earlier pulling back from a session high. Shares remain above the 20-day moving average.
Read
24 sie 2026, 19:26 UTC
Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.
Read
21 sie 2026, 23:21 UTC
Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.
Read
20 sie 2026, 22:56 UTC
Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.
Read
19 sie 2026, 23:01 UTC
Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.
Read
17 sie 2026, 20:06 UTC
Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.
Read
14 sie 2026, 19:56 UTC
Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.
Read
13 sie 2026, 19:56 UTC
Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.
Read
11 sie 2026, 19:46 UTC
Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.
Read
7 sie 2026, 20:05 UTC
Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.
Read
6 sie 2026, 21:02 UTC
Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.
Read
5 sie 2026, 23:02 UTC
Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.
Read
4 sie 2026, 21:02 UTC
Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.
Read
3 sie 2026, 23:01 UTC
Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.
Read
31 lip 2026, 20:02 UTC
Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.
Read
30 lip 2026, 23:01 UTC
Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.
Read
29 lip 2026, 23:56 UTC
Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.
Read
28 lip 2026, 21:02 UTC
Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.
Read
27 lip 2026, 19:26 UTC
Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.
Read
24 lip 2026, 17:36 UTC
Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.
Read
22 lip 2026, 19:26 UTC
Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.
Read
21 lip 2026, 19:51 UTC
Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.
Read
Peer Comparison
Price change
VIRIDIAN THERAPEUTICS INC Forecast
Rating Consensus
By TipRanks
Strong Buy
13 ratings
13
Buy
0
Hold
0
Sell
Based on 13 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$